Introduction Transforming care Investing in our people Accelerating possibilities Protecting the environment Creating value responsibly Appendix Global tax strategy and compliance Partnering for patient care and access Boston Scientific is committed to complying with all applicable The company partners with medical technology groups and regulatory bodies to share best practices and stay informed tax laws, regulations and related disclosure requirements in every about policy developments and emerging areas of regulatory updates. Boston Scientific collaborates with the U.S. jurisdiction where we operate. Our tax professionals adhere Food and Drug Administration (FDA), primarily through the agency’s Digital Health Software Precertification Program, to the highest compliance standards and use standardized, which is focused on giving patients access to emerging health care technologies. We are also part of the Medical Device automated processes to minimize tax risk. The company’s Innovation Consortium, a public-private partnership that engages with government and industry to advance solutions published global tax strategy outlines our approach to taxation, that promote patient access to innovative medical devices and treatments. from risk management and compliance to tax planning and Read more about our work to expand patient access to care in Transforming care. engagement with tax authorities. Political involvement We support public policies that protect and improve patient health, benefit our employees and communities, and promote diversity, equity and inclusion (DE&I). The company advocates for policies that increase access to care and life-saving technologies, and we provide annual updates on political action committee (PAC) activity and other contributions. For example, in 2022 we voiced support for U.S. policies addressing supply chain resiliency to prevent disruptions in care. To advance sound public policy, the Boston Scientific Corporation PAC pools voluntary political contributions from eligible employees and our Board of Directors in accordance with federal law. To learn more about our political involvement, visit our website. 49 2022 Performance Report